Research and Innovation
Addressing Childhood Cancer in New Hampshire
The state of New Hampshire has set aside funds for childhood cancer research and initiatives.
From Plant Virus to Cancer Vaccine
The idea of a vaccine for cancer is not new. But there are differences between human viruses and cancer that make creation of a cancer vaccine particularly challenging.
What is Behind Lasting Immune Response in Some Melanoma Survivors?
Resident memory T cells that enter a patient’s skin and blood during immunotherapy are behind the excellent and long-lasting immune responses to cancer that some survivors develop.
Where Do Prouty Donations Go? Winter 2021
Combining high-dose radiation therapy with immunotherapy to treat cancer, and resolving employment challenges among cancer survivors are among the newest research projects funded by The Prouty.
Piloting a FLASH Radiotherapy Beam for Treatment of Cancer
Researchers convert a standard linear accelerator used for radiation therapy, to deliver an ultra-high-dose rate beam to cancer patients “in a flash.”
What Types of Early-phase Trials are Open Now at NCCC?
In this Q&A series, Jason Faris, MD details some exciting and innovating early-phase trials underway at the cancer center.